Halozyme Therapeutics Spikes Up Following FDA News

By: via Benzinga
Shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO) opened higher Wednesday following an update on meetings with the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.